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Urginea indica Kunth., belonging to the family liliaceae, 
is a perennial glabrous herb commonly known as 
“Indian squill” and locally in Pakistan as “Jungli-
piyaz”, where it grows in Salt Range, Kotli Near Mirpur 
and Mt.Tilla (Baquar, 1989). In the indigenous 
traditional system of medicine, U. indica is reputed for a 
number of therapeutic benefits, for which bulb or 
rhizome are the most commonly employed plant parts. 
It is chiefly used in chronic bronchitis and asthma. The 
other actions attributed to U. indica are anthelmintic, 
cardio-tonic in heart insufficiency, deobstruent, 
digestive, expectorant, stomachic, diuretic, emmena-
gogue and purgative, in addition to its use in calculous 
and paralytic affections, rheumatism, leprosy, skin 
diseases, internal pain and scabies (Baquar, 1989;  
Kirtikar and Basu, 1988; Prajapati et al., 2003). Bulbs 
crushed or sliced are also applied under the sole of feet 
to prevent burning sensation (Kapoor, 1990; 
Usmanghani et al., 1997) and are externally used for 
removing corns and warts (Kapoor, 1990; Prajapati et 
al., 2003). 
Among phytochemical constituents, the glycosides, 
scillarin-A and scillarin-B have been reported to be 
present in fresh squill (Prajapati et al., 2003). Other 
constituents found in squill include flavonoids, 
carbohydrates, antifungal glycoproteins, steroids, 
alkaloids, tannins, coumarins and saponins (Abbas et 
al., 2012; Kameshwari et al., 2012). 
Pharmacological evaluations have revealed the 
presence of antibacterial, antifungal (Shenoy et al., 
2006), laxative and spasmodic (Abbas et al., 2012), 
antioxidant, antiangiogenic and pro-apoptotic activities 
in U. indica (Deepak and Salimath, 2006).  
Abstract 
This study was designed to evaluate bronchodilator and cardio-tonic effects of 
Urginea indica to provide rational for these medicinal uses. U. indica bulb 
extract was studied on rabbit tracheal and guinea-pig atrial preparations 
mounted in tissue baths under simulated physiological conditions. U. indica 
inhibited carbachol (1 µM) and K+ (80 mM)-induced contractions in rabbit 
trachea, similar to dicyclomine, suggesting the presence of anticholinergic and 
calcium channel blocking (CCB) mechanisms in U. indica. Anticholinergic and 
CCB effects of U. indica were respectively confirmed when it shifted the 
carbachol and Ca2+ concentration-response curves rightwards, similar to 
dicyclomine. U. indica (0.01-1 mg/mL) increased force of guinea-pig atrial 
contractions without significantly affecting the rate. These data, indicating that 
U. indica possesses the bronchodilator activity possibly mediated through a 
combination of anticholinergic and Ca2+ antagonist mechanisms together with 
selective positive inotropic effect, provide rational for medicinal applications 
of U. indica in airways and cardiac disorders. 
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Despite of its extensive medicinal application in 
airways hyperactivity disorders and also in cardiac 
disorders, U. indica has not been studied widely to 
evaluate these medicinal uses. This study was aimed to 
provide pharmacological basis for the medicinal use of 
U. indica in broncho-spastic disorders like asthma and 
as cardiac stimulant. 
 
Material and Methods    
Plant material and preparation of crude extract: The bulbs 
of U. indica were collected fresh from fields of Mianwali 
subsequent to the identification of the plant by an 
expert taxonomist at the Institute of Pure & Applied 
Biology, Bahauddin Zakariya University, Multan, 
Pakistan. A specimen of the plant has been deposited at 
herbarium of the same institute (voucher no. P. Fl 59-
1843). The plant material was washed for any 
contaminants and subjected to shade drying. The dried 
plant material (400 g) was ground into coarse powders 
through electrically driven device and the powder was 
soaked in 70% aqueous-methanol (v/v) for three days 
in amber colored glass bottles with occasional shaking. 
The soaked material was passed through double 
layered muslin cloth to remove vegetative debris and 
the obtained fluid was subsequently filtered through 
filter paper (Williamson et al., 1998). The residue was re
-soaked for next three days and the procedure repeated 
twice. The filtrates were evaporated on a rotary 
evaporator (R-210, BUCHI, Switzerland) under reduced 
pressure (-760 mmHg) at  37ºC to a thick, semi-solid 
paste of dark brown colour, the crude extract of U. 
indica bulb yielding 10%. U. indica extract was solubili-
zed in distilled water for all in vitro experiments.  
Animals: Animals used in the study were rabbits of local 
breed and either sex; housed at the Animal House of 
the Aga Khan University, Karachi, maintained at 23-
25ºC.  Animals were provided with standard diet and 
tap water ad libitum. Experiments were performed in 
compliance with the rulings of the Institute of 
Laboratory Animals Resources, Commission on Life 
Sciences, National Research Council (NRC, 2011). 
Chemicals: Acetylcholine chloride (ACh), carbachol 
(CCh) and dicylclomine were purchased from Sigma 
Chemical Co., St. Louis, MO, USA. Chemicals used for 
preparing physiological salt solutions were ethylene-
diamine tetra-acetic acid (EDTA), potassium chloride 
(Sigma Chemical Co.), calcium chloride, glucose, 
magnesium chloride, magnesium sulphate, potassium 
dihydrogen phosphate, sodium dihydrogen phosphate, 
sodium chloride and sodium bicarbonate  (Merck, 
Darmstadt, Germany) . All chemical used were of the 
analytical grade available. Stock solutions of all the 
chemicals were made in distilled water and their 
dilutions were made fresh on the day of experiment. 
The vehicle used for solubilization of drugs had no 
effect on tissue contractility in the control experiments. 
Isolated tissue experiments: Isolated tissue experiments 
were performed following the methods previously 
employed in our laboratory (Gilani et al., 1997; 2007; 
2012). 
Trachea was dissected out and kept in Kreb’s solution. 
The trachea was cleaned free from the surrounding 
fatty tissues and cut into rings having 2-3mm width 
(containing 2 cartilages). Each ring was then opened by 
longitudinal cut on the side opposite to the smooth 
muscle layer in such a way that smooth muscles were in 
between the C-shaped cartilaginous part. The isolated 
preparations were then mounted in tissue baths 
containing Kreb´s solution and aerated with carbogen 
at 37°C. The composition of Kreb’s solution was (mM): 
NaCl 118.2, NaHCO3 25.0, CaCl2 2.5, KCl 4.7, KH2PO4 
1.3, MgSO4 1.2 and glucose 11.7 (pH 7.4). A tension of 1 
g was applied to the tracheal strips continuously and 
equilibrated for 1 h before the addition of any chemical 
substance.  CCh (1 μM) was used to stabilize the 
preparations until constant responses to successive 
treatments were achieved (usually after 3-4 exposures). 
The bronchodilator  activity of the plant extract and 
control drugs was studied on CCh (1 μM) or high K+-
induced sustained contractions, by adding them in a 
cumulative manner. Cumulative curves to CCh were 
constructed using increasing concentration of agonist. 
When a 3-fold increase in concentration produced no 
further increment in response, the tissue was washed to 
re-establish the base-line tension. The CCh CRCs were 
repeated in the presence of increasing concentrations of 
U. indica and dicyclomine. Isometric responses were  
recorded by force transducer (model FORT100) coupled 
to a Transbridge (model TBM4M, World Precision 
Instruments, Hertfordshire, UK) and PowerLab data 
acquisition system (model ML845, AD Instruments, 
Sydney, Australia) and computer running Chart 
software (version 6). 
Paired atria from healthy guinea-pigs were dissected 
out, cleaned of fatty tissues and mounted in 15 mL 
tissue organ baths containing Kreb’s solution, at 32°C 
and the tissues were aerated with carbogen. The tissues 
exhibited spontaneous beating under the resting 
tension of 1 g due to the presence of pacemaker cells. 
An equilibrium period of 30 min was provided before 
the application of any chemical substance. Control 
responses of ACh (0.3 μM) and isoprenaline (1 μM) 
were obtained at least in duplicate. Tension changes in 
the tissue were obtained via a Grass force-displacement 
transducer (model FT-03) and were recorded using 
Grass Model 7 Polygraph. 
Statistical analysis: All the data expressed are mean ± 
standard error of mean (S.E.M., n = number of 
experiments) and the median effective concentration 
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(EC50) with 95%confidence intervals (CI) concentration–
response curves (CRCs) were analyzed by non-linear 
regression using GraphPad program (GraphPAD, 
SanDiego, CA, USA). The statistical parameter applied 
is the Student’s t-test. P<0.05 was considered significant
-ly different. 
 
Results           
U. indica caused relaxation of tracheal preparations pre-
contracted with CCh (1 µM) and K+ (80 mM) with res-
pective EC50 values of 0.139 mg/mL (0.09-0.22, n = 6) 
and 0.79 mg/mL (0.54-1.16, n = 6; Figure 1a). Dicyclo-
mine similarly was found to be more potent in inhibi-
ting CCh (1 µM) induced contractions compared to that 
against high K+ with respective EC50 values of 0.15 µM 
(0.101-0.22, n = 5) and 1.76 (1.23-2.51, n = 5; Figure 1b).  
When studied for its possible anticholinergic action, U. 
indica produced rightward parallel displacement of the 
CCh CRCs without suppression of the maximum 
contractile response at 0.03 mg/mL, followed by non-
parallel shift with suppression of the maximum effect at 
Figure 1: Concentration-dependent inhibitory effects of (A) 
crude extract of U. indica and (B) dicyclomine on K+ (80 mM) 
and carbachol (1 µM)-induced contractions in isolated rabbit 
trachea. Values are shown as mean ± S.E.M., n = 5-6. 
Figure 2: Concentration-response curve of carbachol in the 
absence and presence of (A) crude extract of U. indica and (B) 
dicyclomine in isolated rabbit tracheal preparations. Values 
are expressed as mean ± S.E.M., n = 2-4. 
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next higher concentration (0.1 mg/mL; Figure 2a). 
Dicyclomine (0.03 and 0.1 µM) exhibited a similar 
pattern of shift in CCh CRCs (Figure 2b).  
When studied for its effect on Ca2+ influx, U. indica 
shifted Ca2+ CRCs towards right in a concentration-
dependent manner (0.1-1 mg/mL), similar to 
dicyclomine (0.3-3 µM; Figures 3a and 3b). 
U. indica caused a concentration-dependent (0.01-1.0 
mg/mL) increase in the force of spontaneous 
contractions of paired atria followed by inhibition at the 
higher concentrations (3.0-10.0 mg/mL) without 
significantly affecting the rate of contractions (Figure 4). 
 
Discussion 
U. indica plant has traditionally been used to relieve 
airways disorders including asthma and bronchitis, 
therefore, the current study was undertaken to see 
primarily its bronchodilator effect to rationalize the 
medicinal uses.  
Figure 4: Effect of crude extract of U. indica on force and rate 
of contraction in isolated guinea pig atria. Values are shown 
as mean ± S.E.M., n = 3. 
Figure 3: Concentration-response curve of Ca2+ in the absence and presence of (A) crude extract of U. indica and (B) dicyclomine in 
isolated rabbit trachea. Values are expressed as mean ± S.E.M., n = 4 
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The proposed broncho-relaxant activity of U. indica was 
investigated on CCh (1 µM) and high K+-induced 
contractions in isolated rabbit tracheal preparations.  U. 
indica exhibited relaxant effect on both the contractions 
with higher potency against CCh-induced contraction, 
in a manner similar to dicyclomine, a dual blocker of 
muscarinic receptors and Ca2+ influx (Downie et al., 
1977; McGrath et al., 1964). 
To confirm the antimuscarinic activity, effect of the 
plant extract was studied on CCh-concentration-
response curves constructed in the isolated rabbit 
tracheal preparations. At lower concentration, U. indica 
caused rightward displacement of the curve without 
suppression of the maximum response and at higher 
concentrations, it shifted the curve in a non-parallel 
manner with suppression of the maximum response. 
The parallel shift of CCh-curves at lower concentration 
of U. indica without suppression of maximum response 
is indication for blockade of muscarinic receptors in a 
competitive manner; whereas, non-parallel shift of CCh
-curves observed at higher concentration of U. indica 
with suppression of the maximum response can be 
attributed to the presence of some non-competitive 
inhibitor like that exhibited by a Ca2+-channel blocker. 
The CCB effect was confirmed when pretreatment of 
the tissue with U. indica also produced a concentration-
dependent rightward shift in the Ca2+ concentration-
response curve, similar to dicyclomine.  
The Ca2+ channel blockers have been found to be useful 
in broncho-spastic disorders (Ahmed, 1992; 
Mathewson, 1985) and muscarinic antagonists are also 
included as present day treatment for the relief from 
asthma and similar diseases (Boushey, 2006). The tone 
of bronchiolar smooth muscles is regulated by the 
parasympathetic division of autonomic nervous system 
and reflex increase in parasympathetic activity may 
contribute toward bronchoconstriction because the 
respiratory tract is rich in cholinergic innervations 
through vagal fibers linked to M1 muscarinic receptors 
situated in the mucosal surface of the respiratory tract. 
The mucus secretions are also involved in adding up 
miseries to the pathology of the respiratory tract 
particularly sub-mucosal glands are rich in 
parasympathetic innervations mostly through M3 
receptors and this may be one of the plausible 
explanations using muscarinic antagonist in chronic 
obstructive pulmonary disease as well as asthma 
(Barnes and Hansel, 2004). 
In isolated guinea-pig atria, U. indica produced positive 
inotropic effect at lower concentrations followed by 
inhibition of the contractile force at higher 
concentrations, suggesting the presence of dose-related 
cardio-tonic effect in U. indica. Indian squill is already 
been used in its crude form for the treatment of cardiac 
insufficiency but there is not report on cardiac 
stimulant effect of the plant itself, however the plant is 
reported to contain scillaren-A and scillaren-B 
(Prajapati et al., 2003), the cardio-active glycosides 
producing their effect through inhibition of Na+/K+-
ATPase, similar to that of digitalis glycosides 
(Barceloux, 2008). Cardiac inhibitory effect observed at 
higher concentrations could possibly be the result of the 
presence of Ca2+ channel blocking activity in U. indica. 
These results, showing cardiac stimulant effect in U. 
indica, explain this use of the plant in traditional 
medicine for cardiac insufficiency.  
These investigations indicate that the crude extract of U. 
indica possesses bronchodilator activity possibly 
mediated through a dual blockade of Ca2+ influx and 
muscarininc receptors and cardiac stimulant effect 
through selective inotropic effect, which can be the 
possible reason for its medicinal use in airways 
disorders and cardiac insufficiency.  
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